Mitsubishi UFJ Asset Management Co. Ltd. Buys 43,434 Shares of GE HealthCare Technologies Inc. $GEHC

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 953,383 shares of the company’s stock after buying an additional 43,434 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.21% of GE HealthCare Technologies worth $71,599,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in GEHC. Godsey & Gibb Inc. bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the period. Allianz SE grew its stake in GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares in the last quarter. Oakworth Capital Inc. grew its stake in GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after purchasing an additional 394 shares in the last quarter. Finally, Piscataqua Savings Bank increased its holdings in GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $84.27 on Friday. The company has a market capitalization of $38.41 billion, a PE ratio of 18.48, a P/E/G ratio of 1.85 and a beta of 1.08. The company has a 50-day simple moving average of $82.38 and a two-hundred day simple moving average of $78.41. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $90.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Citigroup upped their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Jefferies Financial Group lifted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Evercore increased their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Finally, UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.